Etomav-MR Tablet is a combination medication containing Etoricoxib 60mg and Thiocolchicoside 4mg, designed to provide effective relief from pain and inflammation associated with musculoskeletal conditions. Etoricoxib, a selective COX-2 inhibitor, works by reducing the production of prostaglandins responsible for pain and inflammation, thereby offering targeted anti-inflammatory and analgesic effects with a lower risk of gastrointestinal side effects compared to traditional NSAIDs. Thiocolchicoside is a muscle relaxant that acts on the central nervous system to alleviate muscle spasms and stiffness, improving mobility and comfort. Together, these components provide a synergistic effect, making Etomav-MR Tablet suitable for managing acute musculoskeletal pain, including lower back pain, strains, sprains, and other soft tissue injuries. It is typically prescribed for short-term use under medical supervision to ensure safety and efficacy. Patients should follow the prescribed dosage and avoid use if allergic to any ingredients or if they have certain medical conditions such as severe liver or kidney impairment. Common side effects may include gastrointestinal discomfort, dizziness, or mild allergic reactions. Always consult a healthcare professional before starting treatment with Etomav-MR Tablet to ensure it is appropriate for your condition.